FDA indicators instruction when GH is accepted; off-label use calls for stable proof, cautious monitoring
https://www.protopage.com/connetngrz#Bookmarks
FDA signals guideline while GH is authorized; off-label use requires effective evidence, cautious monitoring, and obvious consent discussions.